Public health actions to control new SARS-CoV-2 variants

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281 · see citing works

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,633 · see citing works

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557 · see citing works

Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa

Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Doolabh, D., Pillay, S., San, E. J., Msomi, N., et al. (2020) · doi:10.1101/2020.12.21.20248640 · Cited by 2,535 · cited 2× · see citing works

Detection of a SARS-CoV-2 variant of concern in South Africa

Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Doolabh, D., Pillay, S., San, E. J., Msomi, N., et al. (2021) · Nature · doi:10.1038/s41586-021-03402-9 · Cited by 2,510 · see citing works

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.012 · Cited by 1,956 · see citing works

Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data

Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., O’Toole, Á., et al. (2021) · doi:10.1101/2020.12.30.20249034 · Cited by 1,611 · cited 1× · see citing works

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

The COVID-19 Genomics UK (COG-UK) consortium, Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., et al. (2021) · Nature · doi:10.1038/s41586-021-03470-x · Cited by 1,611 · see citing works

Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies

Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · doi:10.1101/2020.12.31.425021 · Cited by 1,178 · cited 2× · see citing works

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.02.003 · Cited by 1,178 · see citing works

SARS-CoV-2 evolution during treatment of chronic infection

Kemp, S. A., Collier, D. A., Datir, R. P., Ferreira, I. A. T. M., Gayed, S., Jahun, A., Hosmillo, M., Rees-Spear, C., Mlcochova, P., Lumb, I. U., et al. (2021) · Nature · doi:10.1038/s41586-021-03291-y · Cited by 1,097 · see citing works

Genetic Variants of SARS-CoV-2—What Do They Mean?

Lauring, A. S., & Hodcroft, E. B. (2021) · JAMA · doi:10.1001/jama.2020.27124 · Cited by 604 · see citing works

International Health Regulations (2005)

Merianos, A., & Peiris, M. J. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67508-3 · Cited by 525 · see citing works

On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community

Goldstein, E., Lipsitch, M., & Çevik, M. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa691 · Cited by 355 · see citing works

Neutralising antibodies in Spike mediated SARS-CoV-2 adaptationPreprint

Kemp, S. A., Collier, D. A., Datir, R. P., et al. (2020) · medRxiv · doi:10.1101/2020.12.05.20241927 · Cited by 180 · see citing works

Travel restrictions hampering COVID-19 response

Devi, S. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30967-3 · Cited by 159 · see citing works

Evidence of the effectiveness of travel-related measures during the early phase of the COVID-19 pandemic: a rapid systematic review

Grépin, K. A., Ho, T. L., Liu, Z., Marion, S., Piper, J., Worsnop, C. Z., & Lee, K. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2020-004537 · Cited by 152 · see citing works

On the effect of age on the transmission of SARS-CoV-2 in households, schools and the communityPreprint

Goldstein, E., Lipsitch, M., & Çevik, M. (2020) · medRxiv · doi:10.1101/2020.07.19.20157362 · Cited by 91 · see citing works

Policy opportunities to enhance sharing for pandemic research

Rourke, M. F., Eccleston-Turner, M., Phelan, A., & Gostin, L. O. (2020) · Science · doi:10.1126/science.abb9342 · Cited by 40 · see citing works

Evidence of the effectiveness of travel-related measures during the early phase of the COVID- 19 pandemic: a rapid systematic reviewPreprint

Grépin, K. A., Ho, T. L., Liu, Z., et al. (2020) · medRxiv · doi:10.1101/2020.11.23.20236703 · Cited by 19 · see citing works

SARS-CoV-2 viral load and shedding kinetics

Puhach, O., Meyer, B., & Eckerle, I. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00822-w · Cited by 421 · see citing works

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

Graham, M. S., Sudre, C. H., May, A., Antonelli, M., Murray, B., Varsavsky, T., Kläser, K., Canas, L. S., Molteni, E., Modat, M., et al. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00055-4 · Cited by 304 · see citing works

Global disparities in SARS-CoV-2 genomic surveillance

Brito, A. F., Semenova, E., Dudas, G., Hassler, G. W., Kalinich, C. C., Kraemer, M. U. G., Ho, J., Tegally, H., Githinji, G., Agoti, C. N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33713-y · Cited by 351 · see citing works

SARS-CoV-2 spreads through cell-to-cell transmission

Zeng, C., Evans, J. P., King, T., Zheng, Y.-M., Oltz, E. M., Whelan, S. P. J., Saif, L. J., Peeples, M. E., & Liu, S.-L. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111400119 · Cited by 246 · see citing works

The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology

Munnink, B. B. O., Worp, N., Nieuwenhuijse, D. F., Sikkema, R. S., Haagmans, B. L., Fouchier, R. A. M., & Koopmans, M. (2021) · Nature Medicine · doi:10.1038/s41591-021-01472-w · Cited by 229 · see citing works

Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA

Earnest, R., Uddin, R., Matluk, N. N., Renzette, N., Turbett, S. E., Siddle, K. J., Loreth, C., Adams, G. C., Tomkins-Tinch, C. H., Petrone, M. E., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100583 · Cited by 200 · see citing works

Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir

Ullrich, S., Ekanayake, K. B., Otting, G., & Nitsche, C. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128629 · Cited by 197 · see citing works

Wastewater surveillance of SARS-CoV-2 across 40 U.S. states from February to June 2020

Wu, F., Xiao, A., Zhang, J., Moniz, K., Endo, N., Armas, F., Bushman, M., Chai, P. R., Duvallet, C., Erickson, T. B., et al. (2021) · Water Research · doi:10.1016/j.watres.2021.117400 · Cited by 176 · see citing works

Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2

Sun, X., Yi, C., Zhu, Y., Ding, L., Xia, S., Chen, X., Liu, M., Gu, C., Lü, X., Fu, Y., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01155-3 · Cited by 141 · see citing works

The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations

Joyce, R., Hu, V. W., & Wang, J. (2022) · Medicinal Chemistry Research · doi:10.1007/s00044-022-02951-6 · Cited by 133 · see citing works

Controlling the pandemic during the SARS-CoV-2 vaccination rollout

Viana, J., van Dorp, C. H., Nunes, A., Gomes, M. C., van Boven, M., Kretzschmar, M., Veldhoen, M., & Rozhnova, G. (2021) · Nature Communications · doi:10.1038/s41467-021-23938-8 · Cited by 131 · see citing works

Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States

Alpert, T., Brito, A. F., Lasek‐Nesselquist, E., Rothman, J. E., Valesano, A. L., MacKay, M. J., Petrone, M. E., Breban, M. I., Watkins, A. E., Vogels, C. B. F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.061 · Cited by 120 · see citing works

Global disparities in SARS-CoV-2 genomic surveillancePreprint

Brito, A. F., Semenova, E., Dudas, G., Hassler, G. W., Kalinich, C. C., Kraemer, M. U. G., Ho, J., Tegally, H., Githinji, G., Agoti, C. N., et al. (2021) · medRxiv · doi:10.1101/2021.08.21.21262393 · Cited by 106 · see citing works

Stabilized coronavirus spike stem elicits a broadly protective antibody

Hsieh, C., Werner, A. P., Leist, S. R., Stevens, L. J., Falconer, E., Goldsmith, J. A., Chou, C., Abiona, O. M., West, A., Westendorf, K., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109929 · Cited by 99 · see citing works

The lag in SARS-CoV-2 genome submissions to GISAID

Kalia, K., Saberwal, G., & Sharma, G. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-01040-0 · Cited by 80 · see citing works

The Emergence of Sars-CoV-2 Variant Lambda (C.37) in South America

Romero, P. E., Dávila-Barclay, A., Salvatierra, G., González, L., Cuicapuza, D., Solís, L., Marcos-Carbajal, P., Huancachoque, J., Maturrano, L., & Tsukayama, P. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00789-21 · Cited by 85 · see citing works

A global aircraft-based wastewater genomic surveillance network for early warning of future pandemics

Li, J., Hosegood, I., Powell, D., Tscharke, B. J., Lawler, J., Thomas, K. V., & Mueller, J. F. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00129-8 · Cited by 67 · see citing works

A Simple Reverse Transcriptase PCR Melting-Temperature Assay To Rapidly Screen for Widely Circulating SARS-CoV-2 Variants

Banada, P. P., Green, R., Banik, S., Chopoorian, A., Streck, D. L., Jones, R., Chakravorty, S., & Alland, D. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00845-21 · Cited by 61 · see citing works

Implementation of a pooled surveillance testing program for asymptomatic SARS-CoV-2 infections in K-12 schools and universities

Bi, C., Mendoza, R., Cheng, H.-T., Pagapas, G., Gabutan, E. C., Khan, N., Hoxie, H., Holmes, K., Gao, N., Lewis, R., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101028 · Cited by 62 · see citing works

Review on molnupiravir as a promising oral drug for the treatment of COVID-19

Zarenezhad, E., & Marzi, M. (2022) · Medicinal Chemistry Research · doi:10.1007/s00044-021-02841-3 · Cited by 60 · see citing works

Changes in symptomatology, re-infection and transmissibility associated with SARS-CoV-2 variant B.1.1.7: an ecological studyPreprint

Graham, M. S., Sudre, C. H., May, A., Antonelli, M., Murray, B. A. K., Varsavsky, T., Kläser, K., Canas, L. S., Molteni, E., Marc Modat, A., et al. (2021) · medRxiv · doi:10.1101/2021.01.28.21250680 · Cited by 63 · see citing works

The potential of saliva as an accessible and sensitive sample type for the detection of respiratory pathogens and host immunity

Laxton, C. S., Peno, C., Hahn, A. M., Allicock, O. M., Perniciaro, S., & Wyllie, A. L. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00135-0 · Cited by 57 · see citing works

Spike Protein Cleavage-Activation Mediated by the SARS-CoV-2 P681R Mutation: A Case-Study From Its First Appearance in Variant of Interest (VOI) A.23.1 Identified in UgandaPreprint

Lubinski, B., Frazier, L. E., Phan, M. V. T., Bugumbe, D., Cunningham, J. L., Tang, T., Daniel, S., Cotten, M. L., Jaimes, J. A., & Whittaker, G. R. (2021) · SSRN Electronic Journal · doi:10.1101/2021.06.30.450632 · Cited by 49 · see citing works

COVID-19 Modeling: A Review

Cao, L., & Liu, Q. (2024) · ACM Computing Surveys · doi:10.1145/3686150 · Cited by 49 · see citing works

Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here

Halperin, D. T., Hearst, N., Hodgins, S., Bailey, R. C., Klausner, J. D., Jackson, H., Wamai, R. G., Ladapo, J. A., Over, M., Baral, S., et al. (2021) · BMC Public Health · doi:10.1186/s12889-021-12082-z · Cited by 45 · see citing works

Large-scale analysis of SARS-CoV-2 synonymous mutations reveals the adaptation to the human codon usage during the virus evolution

Ramazzotti, D., Angaroni, F., Maspero, D., Mauri, M., D’Aliberti, D., Fontana, D., Antoniotti, M., Elli, E. M., Graudenzi, A., & Piazza, R. (2022) · Virus Evolution · doi:10.1093/ve/veac026 · Cited by 49 · see citing works

Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria

Ozer, E. A., Simons, L. M., Adewumi, M. O., Fowotade, A., Omoruyi, E. C., Adeniji, J. A., Olayinka, O. A., Dean, T. J., Zayas, J. P., Bhimalli, P. P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28317-5 · Cited by 45 · see citing works

Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda

Lubinski, B., Frazier, L. E., Phan, M. V. T., Bugembe, D. L., Cunningham, J. L., Tang, T., Daniel, S., Cotten, M. L., Jaimes, J. A., & Whittaker, G. R. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01514-22 · Cited by 43 · see citing works

Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco

Peng, J., Liu, J., Mann, S. A., Mitchell, A. M., Laurie, M. T., Sunshine, S., Pilarowski, G., Ayscue, P., Kistler, A., Vanaerschot, M., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab283 · Cited by 41 · see citing works

Communicate hope to motivate the public during the COVID-19 pandemic

Petersen, M. B., Christiansen, L. E., Bor, A., Lindholt, M. F., Jørgensen, F. J., Adler‐Nissen, R., Roepstorff, A., & Lehmann, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-06316-2 · Cited by 41 · see citing works

SARS-CoV-2 multi-variant rapid detector based on graphene transistor functionalized with an engineered dimeric ACE2 receptor

Romagnoli, A., D’Agostino, M., Pavoni, E., Ardiccioni, C., Motta, S., Crippa, P., Biagetti, G., Notarstefano, V., Rexha, J., Perta, N., et al. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101729 · Cited by 40 · see citing works

Coincident rapid expansion of two SARS-CoV-2 lineages with enhanced infectivity in Nigeria

Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Zayas, J., Bhimalli, P. P., Ash, M. K., et al. (2021) · doi:10.1101/2021.04.09.21255206 · Cited by 34 · see citing works

Public health implications of SARS-CoV-2 variants of concern: a rapid scoping review

Somerville, M., Curran, J., Dol, J., Boulos, L., Saxinger, L. M., Doroshenko, A., Hastings, S. E., Reynolds, B., Gallant, A. J., Shin, H. D., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-055781 · Cited by 37 · see citing works

Point‐of‐Care Platform for Rapid Multiplexed Detection of SARS‐CoV‐2 Variants and Respiratory Pathogens

Trick, A. Y., Chen, F., Chen, L., Lee, P., Hasnain, A. C., Mostafa, H. H., Carroll, K. C., & Wang, T. (2022) · Advanced Materials Technologies · doi:10.1002/admt.202101013 · Cited by 37 · see citing works

An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope

Liu, Z., Xu, W., Chen, Z., Fu, W., Zhan, W., Gao, Y., Zhou, J., Zhou, Y., Wu, J., Wang, Q., et al. (2021) · Protein & Cell · doi:10.1007/s13238-021-00871-6 · Cited by 37 · see citing works

High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples

Pater, A. A., Bosmeny, M. S., Parasrampuria, M., Eddington, S. B., Ovington, K. N., White, A. A., Barkau, C. L., Metz, P. E., Sylvain, R. J., Chilamkurthy, R., et al. (2021) · Journal of Biological Methods · doi:10.14440/jbm.2021.360 · Cited by 36 · see citing works

SARS-CoV-2 Tests: Bridging the Gap between Laboratory Sensors and Clinical Applications

Toropov, N. A., Osborne, E. L., Joshi, L. T., Davidson, J., Morgan, C., Page, J. W., Pepperell, J., & Vollmer, F. (2021) · ACS Sensors · doi:10.1021/acssensors.1c00612 · Cited by 35 · see citing works

Trajectory of Growth of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Houston, Texas, January through May 2021, Based on 12,476 Genome Sequences

Olsen, R. J., Christensen, P. A., Long, S. W., Subedi, S., Hodjat, P., Olson, R., Nguyen, M., Davis, J. J., Yerramilli, P., Saavedra, M. O., et al. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.07.002 · Cited by 30 · see citing works

Data-driven analysis of amino acid change dynamics timely reveals SARS-CoV-2 variant emergence

Bernasconi, A., Mari, L., Casagrandi, R., & Ceri, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-00496-z · Cited by 26 · see citing works

Up State of the SARS-COV-2 Spike Homotrimer Favors an Increased Virulence for New Variants

Giron, C. C., Laaksonen, A., & da Silva, F. L. B. (2021) · Frontiers in Medical Technology · doi:10.3389/fmedt.2021.694347 · Cited by 25 · see citing works

Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays

Virtanen, J. M. E., Uusitalo, R., Korhonen, E. M., Aaltonen, K., Smura, T., Kuivanen, S. H., Pakkanen, S. H., Mero, S., Patjas, A., Riekkinen, M., et al. (2021) · Viruses · doi:10.3390/v13060996 · Cited by 24 · see citing works

In Vitro Effect of Taraxacum officinale Leaf Aqueous Extract on the Interaction between ACE2 Cell Surface Receptor and SARS-CoV-2 Spike Protein D614 and Four Mutants

Tran, H. T. T., Le, N. P. K., Gigl, M., Dawid, C., & Lamy, E. (2021) · Pharmaceuticals · doi:10.3390/ph14101055 · Cited by 26 · see citing works

AI in Combating the COVID-19 Pandemic

Cao, L. (2022) · IEEE Intelligent Systems · doi:10.1109/mis.2022.3164313 · Cited by 22 · see citing works

Garlic peel-based carbon quantum dots as a sustainable alternative for the sensitive and green spectrofluorometric quantification of molnupiravir in pharmaceutical capsules

Saber, Y. A., Hamed, M., Emara, S., Mansour, F. R., Locatelli, M., & Ibrahim, N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40661 · Cited by 24 · see citing works

Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants

Rais, Y., Fu, Z., & Drabovich, A. P. (2021) · Clinical Proteomics · doi:10.1186/s12014-021-09325-x · Cited by 21 · see citing works

SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency

Li, M., Lou, F., & Fan, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00592-6 · Cited by 21 · see citing works

Accuracy in Near-Perfect Virus Phylogenies

Wertheim, J. O., Steel, M., & Sanderson, M. J. (2021) · Systematic Biology · doi:10.1093/sysbio/syab069 · Cited by 17 · see citing works

Wastewater surveillance monitoring of SARS-CoV-2 variants of concern and dynamics of transmission and community burden of COVID-19

Hasing, M. E., Lee, B. E., Gao, T., Li, Q., Qiu, Y., Ellehoj, E., Graber, T. E., Fuzzen, M. L. M., Servos, M. R., Landgraff, C., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2233638 · Cited by 19 · see citing works

Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 variants Alpha and Iota

Petrone, M. E., Rothman, J. E., Breban, M. I., Ott, I. M., Russell, A., Lasek‐Nesselquist, E., Badr, H. S., Kelly, K., Omerza, G., Renzette, N., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03347-3 · Cited by 17 · see citing works

Long-term monitoring of SARS-CoV-2 variants in wastewater using a coordinated workflow of droplet digital PCR and nanopore sequencing.

Vigil, K., Dsouza, N., Bazner, J., Cedraz, F. M.-A., Fisch, S., Rose, J. B., & Aw, T. (2024) · Water Research · doi:10.1016/j.watres.2024.121338 · Cited by 17 · see citing works

Antibody neutralization to SARS-CoV-2 and variants after 1 year in Wuhan, China

Liu, Q., Xiong, Q., Mei, F., Ma, C., Zhang, Z., Hu, B., Xu, J., Jiang, Y., Zhan, F., Zhou, S., et al. (2021) · The Innovation · doi:10.1016/j.xinn.2021.100181 · Cited by 18 · see citing works

Design of SARS-CoV-2 Variant-Specific PCR Assays Considering Regional and Temporal Characteristics

Oh, C., Sashittal, P., Zhou, A., Wang, L., El-Kebir, M., & Nguyen, T. H. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.02289-21 · Cited by 17 · see citing works

Sustainable synthesis of Cu-doped carbon dots from biomass waste for sensitive molnupiravir analysis in pharmaceutical capsules

Elshenawy, E. A., & Mansour, F. R. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.113003 · Cited by 16 · see citing works

Spatial congruency or mismatch? Analyzing the COVID-19 potential infection risk and urban density as businesses reopen

Zhou, L., Li, S., Li, C., Shen, G., Yang, H., Zhu, P., Han, H., & Li, B. (2022) · Cities · doi:10.1016/j.cities.2022.103615 · Cited by 16 · see citing works

Pandemic preparedness means policy makers need to work with social scientists

Pickersgill, M. D., Manda‐Taylor, L., & Niño, N. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00983-7 · Cited by 16 · see citing works

Riding the Pandemic Waves—Lessons to Be Learned from the COVID-19 Crisis Management in Romania

Túri, G., Kassay, J., Virág, A., Dózsa, C., Horváth, K., & Lorenzovici, L. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7070122 · Cited by 16 · see citing works

Viroinformatics investigation of B-cell epitope conserved region in SARS-CoV-2 lineage B.1.1.7 isolates originated from Indonesia to develop vaccine candidate against COVID-19

Ansori, A. N. M., Nidom, R. V., Kusala, M. K. J., Indrasari, S., Normalina, I., Nidom, A. N., Afifah, B., Sari, K. B., Ramadhaniyah, N. L., Alamudi, M. Y., et al. (2021) · Journal of Pharmacy & Pharmacognosy Research · doi:10.56499/jppres21.1101_9.6.766 · Cited by 16 · see citing works

Local emergence and decline of a SARS-CoV-2 variant with mutations L452R and N501Y in the spike proteinPreprint

Mallm, J., Bundschuh, C., Kim, H., Weidner, N., Steiger, S., Lander, I., Börner, K., Bauer, K., Hübschmann, D., Beneš, V., et al. (2021) · medRxiv · doi:10.1101/2021.04.27.21254849 · Cited by 16 · see citing works

Early-stage spatial disease surveillance of novel SARS-CoV-2 variants of concern in Germany with crowdsourced data

Mitze, T., & Rode, J. (2022) · Scientific Reports · doi:10.1038/s41598-021-04573-1 · Cited by 15 · see citing works

Acquired insights from the long-term surveillance of SARS-CoV-2 RNA for COVID-19 monitoring: The case of Monterrey Metropolitan Area (Mexico)

Padilla-Reyes, D. A., Álvarez, M. M., Mora, A., Cervantes-Aviles, P. A., Kumar, M., Loge, F. J., & Mahlknecht, J. (2022) · Environmental Research · doi:10.1016/j.envres.2022.112967 · Cited by 15 · see citing works

Dispersion patterns of SARS-CoV-2 variants Gamma, Lambda and Mu in Latin America and the Caribbean

Gräf, T., Martínez, A. A., Bello, G., Dellicour, S., Lemey, P., Colizza, V., Mazzoli, M., Poletto, C., Cardoso, V. L. O., da Silva, A. F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46143-9 · Cited by 15 · see citing works

A New Way to Trace SARS-CoV-2 Variants Through Weighted Network Analysis of Frequency Trajectories of Mutations

Huang, Q., Zhang, Q., Bible, P. W., Liang, Q., Zheng, F., Wang, Y., Hao, Y., & Liu, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.859241 · Cited by 14 · see citing works

Personalized health and the coronavirus vaccines—Do individual genetics matter?

Valdés‐Fernández, B. N., Duconge-Soler, J., Espino, A. M., Ruaño, G., Campus, P., Juan, S., & Rico, P. (2021) · BioEssays · doi:10.1002/bies.202100087 · Cited by 13 · see citing works

Modeling the Transmission of the SARS-CoV-2 Delta Variant in a Partially Vaccinated Population

de León, U. A.-P., Avila-Vales, E. J., & Huang, K. (2022) · Viruses · doi:10.3390/v14010158 · Cited by 13 · see citing works

A motley of possible therapies of the COVID-19: reminiscing the origin of the pandemic

Kaur, I., Behl, T., Sehgal, A., Singh, S., Sharma, N., Subramanian, V., Fuloria, S., Fuloria, N. K., Sekar, M., Dailah, H. G., et al. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-22345-w · Cited by 10 · see citing works

Structural analysis of a simplified model reproducing SARS-CoV-2 S RBD/ACE2 binding site

Buonocore, M., Santoro, A., Grimaldi, M., Covelli, V., Firoznezhad, M., Rodriquez, M., Santin, M., & D’Ursi, A. M. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11568 · Cited by 11 · see citing works

How much should we sequence? An analysis of the Swiss SARS-CoV-2 surveillance effort

Wegner, F., Gil, B. C., Araud, T., Beckmann, C., Beerenwinkel, N., Bertelli, C., Carrara, M., Cerutti, L., Chen, C., Cordey, S., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.03628-23 · Cited by 11 · see citing works

Digitalization and Exclusion—Digital Divides and Development

Shaban, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-4734-4_4 · Cited by 11 · see citing works

Chemical screen uncovers novel structural classes of inhibitors of the papain-like protease of coronaviruses

Jeong, K., Kim, J., Chang, J., Hong, S., Kim, I., Oh, S.-H., Jeon, S., Lee, J. C., Park, H., Kim, S., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105254 · Cited by 11 · see citing works

Targeting intracellular Neu1 for coronavirus infection treatment

Yang, D., Wu, Y., Turan, I. M., Keil, J. M., Li, K., Chen, M. H., Liu, R., Wang, L., Sun, X., & Chen, G. (2023) · iScience · doi:10.1016/j.isci.2023.106037 · Cited by 11 · see citing works

Comparison of Clinical Characteristics and Outcome of Critically Ill Patients Admitted to Tertiary Care Intensive Care Units in India during the Peak Months of First and Second Waves of COVID-19 Pandemic: A Retrospective Analysis

Dutta, S., Agarwal, M., & Mahajan, A. (2021) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24046 · Cited by 11 · see citing works

An encodable multiplex microsphere-phase amplification sensing platform detects SARS-CoV-2 mutations

Zhong, Z., Wang, J., He, S., Su, X., Huang, W., Chen, M., Zhuo, Z., Zhu, X., Fang, M., Li, T., et al. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114032 · Cited by 11 · see citing works

A map of binary SARS-CoV-2 protein interactions implicates host immune regulation and ubiquitinationPreprint

Kim, D.-K., Weller, B., Lin, C.-W., Sheykhkarimli, D., Knapp, J. J., Kishore, N., Sauer, M., Rayhan, A., Young, V., la Rosa, N. M.-D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.15.433877 · Cited by 11 · see citing works

Sequencing SARS-CoV-2 genomes from saliva

Alpert, T., Vogels, C. B. F., Breban, M. I., Petrone, M. E., Wyllie, A. L., Grubaugh, N. D., & Fauver, J. R. (2021) · Virus Evolution · doi:10.1093/ve/veab098 · Cited by 10 · see citing works

University students' adherence and vaccination attitudes during the COVID‐19 pandemic: Focusing on costs and benefits

Kulcar, V., Straganz, C., Kreh, A., Siller, H. U., File, N., Canazei, M., Bork‐Hüffer, T., & Juen, B. H. (2021) · Applied Psychology Health and Well-Being · doi:10.1111/aphw.12320 · Cited by 9 · see citing works

How to organise travel restrictions in the new future: lessons from the COVID-19 response in Hong Kong and Singapore

Lai, D., Cai, Y., Chan, T. H., Gan, D., Hurson, A. N., & Zhang, Y. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2021-006975 · Cited by 10 · see citing works

Stability and Numerical Simulations of a New SVIR Model with Two Delays on COVID-19 Booster Vaccination

Liu, X., & Ding, Y. (2022) · Mathematics · doi:10.3390/math10101772 · Cited by 9 · see citing works

Inhibition of a broad range of SARS-CoV-2 variants by antiviral phytochemicals in hACE2 mice

Kim, E.-H., Lee, B.-W., Ryu, B., Cho, H. M., Kim, S., Jang, S., Casel, M. A. B., Rollon, R., Yoo, J., Poo, H., et al. (2022) · Antiviral Research · doi:10.1016/j.antiviral.2022.105371 · Cited by 9 · see citing works

Spatiotemporal Analyses of 2 Co-Circulating SARS-CoV-2 Variants, New York State, USA

Russell, A., O’Connor, C., Lasek‐Nesselquist, E., Plitnick, J., Kelly, J. P., Lamson, D. M., & George, K. S. (2022) · Emerging infectious diseases · doi:10.3201/eid2803.211972 · Cited by 8 · see citing works

COVID-19 management landscape: A need for an affordable platform to manufacture safe and efficacious biotherapeutics and prophylactics for the developing countries

Pidiyar, V., Kumraj, G., Ahmed, K., Ahmed, S. M., Shah, S. M., Majumder, P., Verma, B., Pathak, S., & Mukherjee, S. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.05.065 · Cited by 8 · see citing works

Proliferation of SARS-CoV-2 B.1.1.7 Variant in Pakistan-A Short Surveillance Account

Umair, M., Salman, M., Rehman, Z., Badar, N., Ali, Q., Ahad, A., & Ikram, A. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.683378 · Cited by 7 · see citing works

Highly accurate whole-genome imputation of SARS-CoV-2 from partial or low-quality sequences

Ortuño, F. M., Loucera, C., Casimiro‐Soriguer, C. S., Lepe, J. A., Camacho‐Martínez, P., Díaz, L. M., de Salazar, A., Chueca, N., García, F., Pérez-Florido, J., et al. (2021) · GigaScience · doi:10.1093/gigascience/giab078 · Cited by 9 · see citing works

Development and Validation of Two RT-qPCR Diagnostic Assays for Detecting Severe Acute Respiratory Syndrome Coronavirus 2 Genomic Targets across Two Specimen Types

Miller, E. W., Lamberson, C. M., Akabari, R. R., Riddell, S. W., Middleton, F. A., Nasr, M. R., Smith, S. C., & Sperber, S. M. (2022) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2021.12.010 · Cited by 6 · see citing works

The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic wave

Basso, D., Aita, A., Navaglia, F., Mason, P., Moz, S., Pinato, A., Melloni, B., Iannelli, L., Padoan, A., Cosma, C., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02297-1 · Cited by 7 · see citing works

Combined epidemiology and genetic sequencing surveillance in the era of COVID-19 pandemic; Abu Dhabi experience, United Arab Emirates

Abuyadek, R. M., Amirtharaj, F., Marzooqi, S. A., Mahmoud, S., & Hosani, F. I. A. (2023) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2023.105411 · Cited by 7 · see citing works

Immunomolecular assay based on selective virion capture by spike antibody and viral nucleic acid amplification for detecting intact SARS-CoV-2 particles

Wu, X., Liu, J., Zhang, H., Zhou, H., Wang, W., Ma, Y., Shen, S., Cai, X.-F., Huang, A., & Wang, D. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01558-8 · Cited by 6 · see citing works

Development and application of an RT‒PCR assay for the identification of the delta and omicron variants of SARS-COV-2

Shipulin, G. A., Savochkina, Y. A., Константиновна, Ш. А., Glushchenko, E. E., Luparev, A. R., Polyakova, V. A., Danilov, D., Евгеньевна, Д. Е., Vinogradov, K. S., Стеценко, И. Ф., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16917 · Cited by 6 · see citing works

Nucleic Acid Detection through RNA‐Guided Protease Activity in Type III‐E CRISPR‐Cas Systems

He, Q., Lei, X., Liu, Y., Wang, X., Ji, N., Yin, H. H., Wang, H., Zhang, H., & Yu, G. (2023) · ChemBioChem · doi:10.1002/cbic.202300401 · Cited by 6 · see citing works

Polysaccharides from Brown Seaweeds (Padina boergesenii and Sargassum euryphyllum) as Promising Inhibitors of SARS-CoV-2: Characterization, Mechanisms, and Therapeutic Potential

Gheda, S. F., Karkour, A. M., Shafay, S. M. E., GabAllah, M., Cotas, J., & Pereira, L. (2025) · Macromol—A Journal of Macromolecular Research · doi:10.3390/macromol5020018 · Cited by 6 · see citing works

A Look at COVID-19 Global Health Situation, 1-Year Post Declaration of the Pandemic

Sanyaolu, A. O., Marinkovic, A., Prakash, S., Abbasi, A. F., Patidar, R., Williams, M., Zhao, A., Dzando, G., Okorie, C., & Izurieta, R. (2022) · Microbiology Insights · doi:10.1177/11786361221089736 · Cited by 6 · see citing works

Early Introduction and Community Transmission of SARS-CoV-2 Omicron Variant, New York, New York, USA

Liu, D., Cheng, Y., Zhou, H., Wang, L., Fiel, R. H., Gruenstein, Y., Luo, J. J., Singh, V., Konadu, E., James, K. K., et al. (2023) · Emerging infectious diseases · doi:10.3201/eid2902.220817 · Cited by 6 · see citing works

Quantifying the Impact of Lifting Community Nonpharmaceutical Interventions for COVID-19 During Vaccination Rollout in the United States

Matrajt, L., Janes, H., Schiffer, J. T., & Dimitrov, D. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab341 · Cited by 6 · see citing works

Development of primer-probe sets to rapidly distinguish single nucleotide polymorphisms in SARS-CoV-2 lineages

Ealand, C. S., Gordhan, B. G., Machowski, E. E., & Kana, B. D. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1283328 · Cited by 5 · see citing works

Computational Capacity Analysis of Platforms for Low-Cost Autonomous Ultraviolet Germicidal Robots

Pfleger, S. G., & Plentz, P. D. M. (2021) · IEEE International Symposium on Applied Computational Intelligence and Informatics (SACI) · doi:10.1109/saci51354.2021.9465624 · Cited by 5 · see citing works

Mobility as a driver of severe acute respiratory syndrome coronavirus 2 in cancer patients during the second coronavirus disease 2019 pandemic wave

Fong, D., Mair, M. J., Lanthaler, F., Alber, M., & Mitterer, M. (2021) · International Journal of Cancer · doi:10.1002/ijc.33838 · Cited by 4 · see citing works

Effects of COVID-19 on Variations of Taxpayers in Tourism-Reliant Regions: The Case of the Mexican Caribbean

Cruz-Milán, O., & Puls, S. L. (2021) · Journal of risk and financial management · doi:10.3390/jrfm14120578 · Cited by 5 · see citing works

A response playbook for early detection and population surveillance of new SARS-CoV-2 variants in a regional public health laboratory

Barbian, H. J., Kittner, A., Teran, R. A., Bobrovska, S., Qiu, X., English, K., Green, S. J., Ghinai, I., Pacilli, M., & Hayden, M. K. (2024) · BMC Public Health · doi:10.1186/s12889-023-17536-0 · Cited by 4 · see citing works

Applying prospective tree-temporal scan statistics to genomic surveillance data to detect emerging SARS-CoV-2 variants and salmonellosis clusters in New York City

Greene, S. K., Latash, J., Peterson, E. R., Levin‐Rector, A., Luoma, E., Wang, J. C., Bernard, K., Olsen, A., Li, L., Waechter, H., et al. (2025) · International Journal of Epidemiology · doi:10.1093/ije/dyaf032 · Cited by 4 · see citing works

Is the Increased Transmissibility of SARS-CoV-2 Variants Driven by within or Outside-Host Processes?

Arav, Y., Fattal, E., & Klausner, Z. (2022) · Mathematics · doi:10.3390/math10193422 · Cited by 5 · see citing works

Trends and impacts of SARS-CoV-2 genome sharing: a comparative analysis of China and the global community, 2020–2023

Feng, Y., Chen, S., Wang, A., Zhao, Z., & Chen, C. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1491623 · Cited by 3 · see citing works

Public health actions to control new SARS-CoV-2 variants [commentary].

Grubaugh, N. D., Hodcroft, E. B., Fauver, J. R., Phelan, A., & Çevik, M. (2021) · doi:10.48350/152394

Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021

Galloway, S. E., Paul, P., MacCannell, D., Johansson, M. A., Brooks, J. T., MacNeil, A., Slayton, R. B., Tong, S., Silk, B. J., Armstrong, G. L., et al. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7003e2 · Cited by 609 · see citing works

An action plan for pan-European defence against new SARS-CoV-2 variants

Priesemann, V., Balling, R., Brinkmann, M. M., Ciesek, S., Czypionka, T., Eckerle, I., Giordano, G., Hanson, C., Hel, Z., Hotulainen, P., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00150-1 · Cited by 107 · see citing works

Spatiotemporal Analyses of 2 Co-Circulating SARS-CoV-2 Variants, New York State, USA

Russell, A., O’Connor, C., Lasek‐Nesselquist, E., Plitnick, J., Kelly, J. P., Lamson, D. M., & George, K. S. (2022) · Emerging infectious diseases · doi:10.3201/eid2803.211972 · Cited by 8 · see citing works

Report Outlines Strategy for Surveillance of Emerging Coronavirus Variants

Stephenson, J. (2021) · JAMA Health Forum · doi:10.1001/jamahealthforum.2021.0246